Armata Pharmaceuticals Inc ARMP:NYSE American

Last Price$4.50AMEX Previous Close - Last Trade as of 8:00PM ET 12/03/21
AMEX 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$4.25 (5)
Ask (Size)$5.98 (1)
Day Low / HighN/A - N/A
Volume14.0 K

View Biotechnology IndustryPeer Comparison as of 12/03/2021


Armata Pharmaceuticals Inc ( NYSE MKT LLC )

Price: $4.50
Change: -0.41 (8.35%)
Volume: 14.0 K
8:00PM ET 12/03/2021

Palatin Technologies Inc ( NYSE MKT LLC )

Price: $0.53
Change: -0.03 (5.23%)
Volume: 10.5 M
8:00PM ET 12/03/2021

Puma Biotechnology Inc ( NASDAQ )

Price: $2.99
Change: -0.02 (0.66%)
Volume: 834.2 K
4:00PM ET 12/03/2021

Savara Inc ( NASDAQ )

Price: $1.06
Change: -0.03 (2.75%)
Volume: 675.8 K
4:00PM ET 12/03/2021

Concert Pharmaceuticals Inc ( NASDAQ )

Price: $3.40
Change: -0.01 (0.29%)
Volume: 167.7 K
4:00PM ET 12/03/2021

Read more news Recent News

Armata Cleared by US FDA to Start Trial of Staphylococcus Aureus Bacteremia Treatment; Shares Rise
3:35PM ET 11/18/2021 MT Newswires

Armata Pharmaceuticals (ARMP) said Thursday the US Food and Drug Administration approved the company's investigational new drug application to start a...

Armata Pharmaceuticals Secures $7 Million Investment From Cystic Fibrosis Foundation, Innoviva; Shares Rise Friday Morning
11:05AM ET 10/29/2021 MT Newswires

Armata Pharmaceuticals (ARMP) said late Thursday that the Cystic Fibrosis Foundation and Innoviva Strategic Opportunities have made a combined equity...

Top Premarket Decliners
8:15AM ET 10/11/2021 MT Newswires

MMTEC (MTC), the Chinese online trading service platform company, led the decliners, with shares down 8.2% lower. Opera Ltd. (OPRA), the Norwegian-based...

Armata Pharmaceuticals Says CEO Retiring; Successor Named
10:04AM ET 8/02/2021 MT Newswires

Armata Pharmaceuticals (ARMP) said Monday that Chief Executive Officer Todd Patrick is retiring, effective immediately. President and Chief Development...

View all Commentary and Analysis

The Best Of Backtesting - Week Oct. 4
10:20AM ET 10/09/2021 Seeking Alpha

BiomX: Undervalued With Multiple Upcoming Catalysts
6:42PM ET 10/06/2021 Seeking Alpha

The Best Of Backtesting - Week Aug. 30
3:51PM ET 9/02/2021 Seeking Alpha

Company Profile

Business DescriptionArmata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA. View company web site for more details
Address4503 Glencoe Avenue
Los Angeles, California 90292
Number of Employees31
Recent SEC Filing11/10/202110-Q
Chief Executive Officer & DirectorBrian C. Varnum
Vice President-OperationsDuane A. Morris
Chief Financial OfficerSteven Robert Martin
Vice President-Clinical DevelopmentMina Pastagia

Company Highlights

Price Open$4.83
Previous Close$4.91
52 Week Range$2.56 - 10.48
Market Capitalization$121.9 M
Shares Outstanding27.1 M
SectorHealth Technology
Next Earnings Announcement03/17/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.12
Beta vs. S&P 500N/A
Net Profit Margin-594.94%
Return on Equity-90.20%

Analyst Ratings as of 11/24/2021

Consensus RecommendationConsensus Icon
Powered by Factset